These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 187990)

  • 21. 17-Hydroxyprogesterone level as a marker for corpus luteum function in aborters versus nonaborters.
    Check JH; Vaze MM; Epstein R; Wu CH; Quattrocchi J; Vetter B
    Int J Fertil; 1990; 35(2):112-5. PubMed ID: 1970979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
    Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
    J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of partial molar pregnancy.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
    Nagelberg SB; Rosen SW
    Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
    Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum levels of estradiol, progesterone and human chorionic gonadotropin in ectopic pregnancy and their correlation with endometrial histologic findings.
    Guillaume J; Benjamin F; Sicuranza B; Wang CF; Garcia A; Friberg J
    Surg Gynecol Obstet; 1987 Jul; 165(1):9-12. PubMed ID: 3589936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theca lutein ovarian cyst may be pathognomonic for trophoblastic neoplasia.
    Kohorn EI
    Obstet Gynecol; 1983 Sep; 62(3 Suppl):80s-81s. PubMed ID: 6308531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease.
    Cole LA
    J Reprod Med; 1998 Jan; 43(1):3-10. PubMed ID: 9475142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the clinical laboratory detection of gestational trophoblastic disease.
    Seki K; Matsui H; Sekiya S
    Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer?
    Alazzam M; Young T; Coleman R; Hancock B; Drew D; Wilson P; Tidy J
    Gynecol Oncol; 2011 Sep; 122(3):595-9. PubMed ID: 21684585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
    Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
    J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
    Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
    Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
    Kunhardt J; Calderón J; Rodríguez S; Fletcher P; Ayala A; Reyes V
    Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
    [No Abstract]   [Full Text] [Related]  

  • 40. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.